Kymera Therapeutics, Inc. (KYMR)
NASDAQ: KYMR · Real-Time Price · USD
123.64
+2.14 (1.76%)
Aug 21, 2026, 11:30 AM EDT - Market open

Kymera Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
124.48357.01120.26109.9768.447.98
Short-Term Investments
566.51491.27368.49264.92338.77394.44
Cash & Short-Term Investments
690.99848.28488.74374.88407.17442.42
Cash Growth
3.84%73.56%30.37%-7.93%-7.97%49.36%
Accounts Receivable
20--18.762.540.14
Receivables
20--18.762.540.14
Prepaid Expenses
26.2822.9421.5211.679.718.72
Total Current Assets
737.27871.21510.27405.32419.42451.27
Property, Plant & Equipment
81.0785.5397.86101.0822.2421.31
Long-Term Investments
813.9771.16362.1661.43152.33125.19
Other Long-Term Assets
13.2114.917.747.939.158.14
Total Assets
1,6451,743978.04575.76603.13605.91

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
8.924.015.997.084.344.01
Accrued Expenses
48.4842.2734.8733.8627.522.97
Current Portion of Leases
13.713.7613.116.353.943.6
Current Unearned Revenue
-22.9313.5837.8835.2661.74
Other Current Liabilities
0.240.240.220.520.30.23
Total Current Liabilities
71.3383.2167.7785.6971.3492.54
Long-Term Leases
64.8668.574.6578.3313.3914.36
Long-Term Unearned Revenue
-11.44-16.772839.3
Other Long-Term Liabilities
----0.250.07
Total Liabilities
136.19163.15142.42180.79112.98146.27

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0.010.010.010.010.010.01
Additional Paid-In Capital
2,7132,6441,592926.27878.88689.28
Retained Earnings
-1,196-1,066-754.61-530.75-383.79-228.98
Comprehensive Income & Other
-7.161.8-1.49-0.55-4.95-0.66
Total Common Equity
1,5091,580835.62394.97490.15459.64
Shareholders' Equity
1,5091,580835.62394.97490.15459.64
Total Liabilities & Equity
1,6451,743978.04575.76603.13605.91

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
78.5682.2587.7684.6717.3417.96
Net Cash (Debt)
1,4261,537763.14351.64542.16549.64
Net Cash Growth
62.57%101.43%117.02%-35.14%-1.36%24.71%
Net Cash Per Share
15.2918.1910.176.0210.0511.45
Filing Date Shares Outstanding
83.1581.6464.9461.1155.1851.67
Total Common Shares Outstanding
82.7981.3264.8955.5955.0451.5
Working Capital
665.94788442.5319.63348.07358.73
Book Value Per Share
18.2319.4212.887.118.918.93
Tangible Book Value
1,5091,580835.62394.97490.15459.64
Tangible Book Value Per Share
18.2319.4212.887.118.918.93
Machinery
16.3715.7714.756.745.84.02
Leasehold Improvements
43.1542.9944.017.87.87.74
SEC Filings: 10-K · 10-Q